Back to search

Switzerland· 36527002

ferro sanol, gélules à libération modifiée

A ferrous glycine sulfate product, registered in Switzerland by UCB-Pharma SA and dispensed under Swissmedic category D. The same ATC class is registered in 5 of our 19 countries.

Cat D (Swissmedic)ATC B03AA01

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedferro sanol, gélules à libération mod…ATCB03AA01REGISTER NO.36527002PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Ferrous glycine sulfate is registered in 5 of 19 countries.

Countries holding a registration under ATC B03AA01 (ferrous glycine sulfate), each read from that country’s own register.

  • This record: Switzerland
  • 4 of them publish a price we can compare per daily dose

Ferrous glycine sulfate · ATC B03AA01

5 / 19 countries

  • Denmark
  • Finlandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous glycine sulfate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • Switzerland: $0.61 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Ferrous glycine sulfate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Manufacturer
UCB-Pharma SA
Country
Switzerland (CH)
ATC code
B03AA01
ATC class
Ferrous glycine sulfate
Defined daily dose
0.2 g, O
Swissmedic category
D
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for ferrous glycine sulfate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ferrous glycine sulfate · interactions on record

10 records

10 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/53f4a0ec-6286-4484-a513-73ab36c882fa
GET /v1/drugs/53f4a0ec-6286-4484-a513-73ab36c882fa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about ferrous glycine sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.